Login / Signup

The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.

Masood Faghih DinevariFarzaneh JafarzadehAmirreza Jabbaripour SarmadianSamaneh AbbasianZeinab NikniazAli Riazi
Published in: BMC gastroenterology (2023)
This study has been registered to the Iranian Registry of Clinical Trials (IRCT) with the approval number IRCT20220104053626N2 on the date of 13/02/2022.
Keyphrases
  • clinical trial
  • irritable bowel syndrome
  • randomized controlled trial
  • physical activity
  • open label
  • phase ii